EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

T, NK, then macrophages: Recent advances and challenges in adaptive immunotherapy from human pluripotent stem cells

Su Hang, Nan Wang, Ryohichi Sugimura

Differentiation · 2023

DOI: 10.1016/j.diff.2023.01.001 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Differentiation, 2023. Verfasst von Su Hang und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong. Hauptthemen laut MEDLINE: Receptors, Chimeric Antigen, Pluripotent Stem Cells, Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Chimeric AntigenPluripotent Stem CellsNeoplasmsHumansImmunotherapyKiller Cells, NaturalMacrophages

Substanzen

Receptors, Chimeric Antigen

Autor:innen und Institutionen

  • School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong.
  • School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong; Centre for Translational Stem Cell Biology, Hong Kong. Electronic address: rios@hku.hk.

Zitieren

APA

Hang, S., Wang, N., & Sugimura, R. (2023). T, NK, then macrophages: Recent advances and challenges in adaptive immunotherapy from human pluripotent stem cells. Differentiation. https://doi.org/10.1016/j.diff.2023.01.001

Vancouver

Hang S, Wang N, Sugimura R. T, NK, then macrophages: Recent advances and challenges in adaptive immunotherapy from human pluripotent stem cells. Differentiation. 2023. doi:10.1016/j.diff.2023.01.001

BibTeX
@article{Hang2023,
  author = {Hang, Su and Wang, Nan and Sugimura, Ryohichi},
  title = {T, NK, then macrophages: Recent advances and challenges in adaptive immunotherapy from human pluripotent stem cells},
  journal = {Differentiation},
  year = {2023},
  doi = {10.1016/j.diff.2023.01.001}
}
Kostenlos starten →